Real-time enrollment status for this atypical hemolytic-uremic syndrome clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:43 AM UTC
| NCT Number | NCT01522183 |
| Recruiting Status | Recruiting |
| Condition | Atypical Hemolytic-Uremic Syndrome |
| Phase | Clinical Trial |
| Target Enrollment | 3,000 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Alexion Pharmaceuticals, Inc. |
| Last Updated on CT.gov | September 16, 2025 (Sep 16, 2025) |
As of July 13, 2026: Clinical trial NCT01522183 is currently recruiting participants. This clinical trial study for atypical hemolytic-uremic syndrome is actively seeking new participants at 9 locations across the United States. The study is sponsored by Alexion Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT01522183 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT01522183 was last updated Sep 16, 2025 (September 16, 2025). HelloStudys verifies this status automatically.